Outcome of Board Meeting held on Friday, May 15, 2026
DCMNVL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DCM Nouvelle Limited reported audited financial results for FY2026 ending March 31. Standalone revenue declined to ₹101,517 lakhs from ₹105,845 lakhs in FY2025 (a 4.1% drop). The company posted a standalone net loss of ₹1,802 lakhs compared to a profit of ₹2,267 lakhs in FY2025. This sharp decline was primarily due to a ₹3,561 lakh provision for impairment in the value of its investment in subsidiary DCM Nouvelle Specialty Chemicals Limited, along with ₹186 lakhs impact from new labour codes. On a consolidated basis, revenue was ₹102,707 lakhs (down from ₹107,589 lakhs) with net profit of only ₹164 lakhs versus ₹602 lakhs previously. The chemical subsidiary reported a loss of ₹1,611 lakhs. Statutory auditors Walker Chandiok & Co LLP issued an unmodified (clean) opinion on both standalone and consolidated results.
The stock may face negative sentiment due to revenue decline and significant loss on standalone basis. However, the clean audit opinion and positive operating cash flow (₹5,984 lakhs standalone) provide some comfort. The large impairment charge is a one-time item but signals stress in the chemical subsidiary business.